HIV News and Research

RSS

Darunavir - first molecule to treat drug-resistant HIV

Doctors have their first FDA-approved tool to treat drug-resistant HIV thanks to a new molecule created by a Purdue University researcher.

2 Aug 2006

Protein CD86 raises antibody output

Cancer immunologists here have discovered how a protein on the surface of antibody-making immune cells boosts the amount of antibody the cells make.

2 Aug 2006

Practical advice and individualized attention can help people with HIV stick to a consistent drug regimen

The studies were too different to combine results, but the review team found that the most successful programs emphasized "practical medicine management," one-on-one attention or a 12-week or longer duration.

2 Aug 2006

Government money for sexual health used to pay off debts

According to the Independent Advisory Group on Sexual Health and HIV (IAG) in the UK, a significant amount of the £300million set aside for sexual health is being used by NHS trusts to reduce their financial deficits.

2 Aug 2006

HIV mutation clue to why only some people develop AIDS dementia

The study of 18 HIV-positive subjects shows that HIV in the brain and central nervous system is genetically different from HIV that lives in the blood and peripheral tissues.

26 Jul 2006

Deadly duo of crime and drug abuse can be cut by effective treatments

According to a landmark scientific report released by the National Institute on Drug Abuse (NIDA), money would be saved and crime would be reduced if communities put into place effective treatments for drug abuse and addiction.

26 Jul 2006

Healthcare providers react more positively to men than women who reveal they're gay

Men and people over 40 are much more likely to report positive experiences when they tell healthcare providers they are not heterosexual, according research in the latest UK-based Journal of Advanced Nursing.

24 Jul 2006

Going to court to get access to essential medicines should only be used as a last resort

Going to court to get access to essential medicines may be necessary and has been successful in several cases, but it should only be used as a last resort, according to an article in this week's issue of The Lancet.

21 Jul 2006

Matchstick-sized contraceptive implant that lasts for three years

The Food and Drug Administration in the U.S. has given approval for a new contraceptive which will protect women from pregnancy for as long as three years.

20 Jul 2006

New laser test screens for Hepatitis B

The U.S. Food and Drug Administration has given the go-ahead for a device, called Cell-Dyn Ruby, which uses laser optics and provides diagrams showing changes in white and red blood cells and platelets.

20 Jul 2006

Latest sequencing targets for NHGRI

The National Human Genome Research Institute (NHGRI) has announced several new sequencing targets including the Northern white-cheeked gibbon (Nomascus leucogenys).

19 Jul 2006

Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adult

A new analysis of existing research offers confirmation that taking a break from AIDS drugs is a bad idea for HIV patients with uncontrolled cases of the disease.

19 Jul 2006

Highly active antiretroviral therapies associated with reduced infections in HIV-infected children

Since the introduction of highly active antiretroviral therapies, there has been a substantial reduction of opportunistic infections and other infections in HIV-infected children, such as pneumonia and tuberculosis.

19 Jul 2006

New research shows how 'genetic fingerprinting' can be used to track the spread of STDs

New research shows it could be possible to follow the spread of bacterial sexually transmitted diseases (STDs) through the population by tracking the individuals in a city infected with the same strain of the bacterium.

19 Jul 2006

Clinton Foundation seals deal in Nigerian AIDS fight

The Clinton Foundation, an AIDS charity set up by former U.S. President Bill Clinton, has signed a deal with Nigeria to make cheap AIDS drugs available to fight the disease in Africa's most populous nation.

18 Jul 2006

FDA approves Atripla for the treatment of HIV-1 infection in adults

Bristol-Myers Squibb Company and Gilead Sciences have announced the U.S. Food and Drug Administration (FDA) has granted approval of Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) for the treatment of HIV-1 infection in adults.

13 Jul 2006

FDA approves Atripla three-drug combination tablet for treatment of HIV-1

FDA approves Atripla Tablets, a fixed-dose combination of three widely-used antiretroviral drugs.

12 Jul 2006

Male circumcision the key to controlling the spread of AIDS in Africa

In what is being coined as a 'landmark' trial, researchers have found evidence that male circumcision (MC) could reduce the chance of becoming infected with HIV.

10 Jul 2006

Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates

Using a synthetic peptide modeled after the protein that the human immunodeficiency virus (HIV) uses to enter cells, a multi-institutional research team has created quantum dots that can penetrate the cell membrane and image internal structures in a cell.

10 Jul 2006

Psychological torture used on Bulgarian nurses in Libya

At a hearing in Tripoli the defence team representing a Palestinian doctor and five Bulgarian nurses accused of deliberately infecting more than 400 Libyan children with HIV-tainted blood, have said psychological-torture measures were used against the nurses.

6 Jul 2006